
Your Feed
Promising Result from a Novel Mezigdomide Combination Trial | Fredrik Schjesvold, MD, PhD | #EHA2025
Promising Result from a Novel Mezigdomide Combination Trial | Fredrik Schjesvold, MD, PhD | #EHA2025
MagnetisMM-6: Elranatamab+Dara+Len in ND Transplant-Ineligible MM | Meletios Dimopoulos, MD | #EHA2025
MagnetisMM-6: Elranatamab+Dara+Len in ND Transplant-Ineligible MM | Meletios Dimopoulos, MD | #EHA2025
Updated DREAMM-8 Data: Belantamab-Pomalidomide-Dex in Myeloma | Meletios Dimopoulos, MD | #EHA2025
Updated DREAMM-8 Data: Belantamab-Pomalidomide-Dex in Myeloma | Meletios Dimopoulos, MD | #EHA2025
Real-World Evidence for Teclistamab in Myeloma | Dr. Rakesh Popat Shares #EHA2025 Insights
Real-World Evidence for Teclistamab in Myeloma | Dr. Rakesh Popat Shares #EHA2025 Insights
First-In-Human Study for Novel Trispecific Antibody | Rakesh Popat, BSc, MBBS, MRCP, PhD | #EHA2025
First-In-Human Study for Novel Trispecific Antibody | Rakesh Popat, BSc, MBBS, MRCP, PhD | #EHA2025
What is extramedullary disease and how is it treated?
Is it safe to be intimate with your partner who is on chemo and radiation?


